VagiVital Intimate Calming Gel is a tailored product that complements Peptonic's existing range of clinically proven intimate self-care products. Based on Peptonic's proprietary gel base, AktivGel, the formula combines exceptional moisturizing properties with the soothing amino acid glycine, renowned for its ability to calm sensitive skin and maintain optimal moisture balance.

The new product is specifically formulated to alleviate irritation, redness, and sensitivity in the external intimate area. Its pH-balanced and fragrance-free formula makes it suitable even for the most sensitive skin. For more persistent symptoms, it is recommended to use the product in combination with VagiVital AktivGel, which provides intensive hydration and relief for dry and fragile vaginal tissues when applied intravaginally. Together, these two products offer a comprehensive solution for the care of both internal and external genital areas, free from hormones and unnecessary additives. VagiVital Intimate Calming Gel is available for purchase through pharmacies and the company's webshop. For more information, please visit: www.vagivital.com

For further information, please contact:
Anna Linton, CEO, Peptonic Medical AB                                                                                                      
Email: anna.linton@peptonicmedical.se                                                                                                                    
Phone: +46 70-244 92 07

About Peptonic Medical AB                                                                                                         
PEPTONIC medical AB (publ) is a pioneering Swedish medtech company specializing in the development and sale of clinically proven self-care products for women's intimate health. Through its brands VagiVital and Vernivia, the Company offers a broad over-the-counter portfolio of effective and gentle products designed to help women understand, treat, and prevent common medical conditions in the intimate area. Peptonic's growth strategy centers on geographic expansion, particularly in the U.S. and Europe, while continually enhancing its product portfolio through in-house development and strategic acquisitions.

The Company is headquartered in Stockholm, Sweden, and operates a subsidiary, Common Sense Marketing Inc., in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.